与认知表现和阿尔茨海默病生物标志物相关的饮食频率,时间和持续时间
Dora Brikou1, Maria-Anna Dimopoulou1, Archontoula Drouka1
1Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.
The Journal of nutrition
|May 26, 2024
概括
一天中吃得更频繁与成年人更好的认知功能有关. 这项研究表明,食时间和频率可能是认知健康和阿尔茨海默病 (AD) 的早期指标.
科学领域:
- 神经科学是一个神经科学.
- 营养科学 营养科学
- 老年学是一门学科.
背景情况:
- 进食时间和认知衰退之间的关系是研究不足的.
- 了解暂时的饮食模式可能会提供对认知健康的见解.
研究的目的:
- 调查饮食频率,时间和时间窗口与认知表现之间的关联.
- 探索与阿尔茨海默病 (AD) 生物标志物相关的这些关系.
主要方法:
- 利用了来自神经退行性起始纵向生物标志物调查 (ALBION) 队列的横截面数据.
- 使用神经心理测试评估认知表现.
- 通过24小时回忆测量大脑脊髓液和饮食模式中的粉样蛋白β (Aβ42).
主要成果:
- 更高的饮食频率与全球认知,执行功能和语言表现正相关.
- 每天更多的进食 (5-6或>6) 与更好的全球和记忆z分数有关.
- 最后一顿饭的较早时间与语言表现的改善有关;没有发现与AD生物标志物的联系.
结论:
- 不太频繁的进食和较早的进食时间可能表明认知表现较差.
- 时间性饮食模式可能是与AD病理学相关的行为或代谢变化的早期标志物.
相关概念视频
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Cognitive Development During Adulthood
93
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
93
Dementia
111
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
111


